financetom
Business
financetom
/
Business
/
Merck signs $3.3 bln deal for experimental cancer drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Merck signs $3.3 bln deal for experimental cancer drug
Nov 15, 2024 12:43 PM

Nov 14 (Reuters) - Merck ( MRK ) has signed a licensing

agreement worth up to $3.3 billion with Shanghai-based LaNova

Medicines to develop, make and sell an experimental cancer drug,

the two companies said on Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Toyota, Honda Shares Gain as US-Japan Trade Deal Cuts Auto Tariffs
Toyota, Honda Shares Gain as US-Japan Trade Deal Cuts Auto Tariffs
Jul 23, 2025
05:38 AM EDT, 07/23/2025 (MT Newswires) -- Toyota Motor ( TM ) and Honda Motor ( HMC ) shares surged more than 12% and 10%, respectively, during premarket Wednesday, following the completion of a significant trade agreement between the US and Japan. The deal reduces tariffs on Japanese auto exports to the US from the previously threatened 25% to 15%,...
Green hydrogen retreat poses threat to emissions targets
Green hydrogen retreat poses threat to emissions targets
Jul 23, 2025
MADRID/LONDON/BERLIN (Reuters) -Green hydrogen developers are cancelling projects and trimming investments around the world, raising the prospect of longer than targeted reliance on fossil fuels. The challenges facing the sector have exposed its initial ambitions as unrealistic. Hard-to-electrify industries that were seen as ideal candidates for green hydrogen, such as steelmaking and long-distance transportation, have found that transition to the...
Update: Texas Instruments Shares Down Pre-Bell After Q2 Results, Q3 Guidance
Update: Texas Instruments Shares Down Pre-Bell After Q2 Results, Q3 Guidance
Jul 23, 2025
05:37 AM EDT, 07/23/2025 (MT Newswires) -- Texas Instruments ( TXN ) shares were down nearly 12% in recent premarket activity Wednesday after the company reported its Q2 results and issued a Q3 guidance overnight. The company posted Q2 earnings late Tuesday of $1.41 per diluted share, up from $1.22 a year earlier. Analysts polled by FactSet expected $1.36. Revenue...
Copyright 2023-2026 - www.financetom.com All Rights Reserved